DNCA Finance’s Boston Scientific BSX Stock Holding History

DNCA Finance’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.83M	Buy	+61,000	New	+$4.88M	0.22%	63

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DNCA Finance's BSX Position: Q1 2026 in Review

DNCA Finance opened a new position in Boston Scientific (BSX) in Q1 2026: 61,000 shares worth $3.83M. The stake represents 0.22% of the portfolio and ranks #63 among its holdings.

1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

DNCA Finance held 61,000 shares of Boston Scientific worth $3.83M as of Q1 2026.
Boston Scientific was a new DNCA Finance position in Q1 2026.
Boston Scientific made up 0.22% of DNCA Finance's portfolio in Q1 2026, its #63 holding.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on DNCA Finance's 13F filing for Q1 2026, filed 14 May 2026.